Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net revenues:
Net commercial product revenues	$ 244,000	$ 632,000	$ 1,710,000
Total net revenues	244,000	632,000	1,710,000
Costs and expenses:
Cost of commercial product revenues	3,004,000	1,558,000	1,051,000
Research and development	4,125,000	5,992,000	6,073,000
Selling, general and administrative	5,838,000	5,389,000	5,068,000
Total costs and expenses	12,967,000	12,939,000	12,192,000
Loss from operations	(12,723,000)	(12,307,000)	(10,482,000)
Other Income and Expense
Gain (loss) from investment in Resonant LLC joint venture		3,142,000	(238,000)
Adjustments to fair value of warrant derivatives	4,852,000	480,000	(1,551,000)
Adjustment to warrant exercise price	(537,000)
Other income	13,000	434,000	140,000
Other expense	(207,000)		(42,000)
Net loss	$ (8,602,000)	$ (8,251,000)	$ (12,173,000)
Basic and diluted net loss per common share	$ (0.44)	$ (0.64)	$ (1.71)
Basic and diluted weighted average number of common shares outstanding	19,706,292	12,793,929	7,123,817